DSpace DSpace UPC
 Català   Castellano   English  

E-prints UPC >
Altres >
Enviament des de DRAC >

Empreu aquest identificador per citar o enllaçar aquest ítem: http://hdl.handle.net/2117/13107

Arxiu Descripció MidaFormat
Preventing ventricular_Erik Cobo.pdf1,92 MBAdobe PDFThumbnail
Veure/Obrir

Citació: Stockburger, M. [et al.]. Preventing ventricular dysfuction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF). "European journal of heart failure", Juny 2011, vol. 13, núm. 6, p. 633-641.
Títol: Preventing ventricular dysfuction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF)
Autor: de Teresa, Eduardo; Navarro-López, Francisco; Navarro, Xavier; Stockburger, Martin; Gómez-Doblas, Juan José; Lamas, Gervasio; Alzueta, Javier; Fernández-Lozano, Ignacio; Cobo Valeri, Erik Veure Producció científica UPC; Wiegand, Uwe; Fernández de la Concha, Joaquín
Data: jun-2011
Tipus de document: Article
Resum: Aims Previous experimental and clinical studies have consistently suggested that right ventricular (RV) apical pacing has important adverse effects. Ventricular pacing (VP), however, is required, and cannot be reduced in many patients with atrioventricular (AV) block. The PREVENT-HF study was an international randomized trial that explored differences in left ventricular (LV) remodelling during RV apical vs. biventricular (BIV) pacing in patients with AV block. Methods and Results Patients with an expected VP prevalence ≥80% were assigned to RV apical or BIV pacing. The primary endpoint was the change in LV end-diastolic volume (EDV) >12 months. Secondary endpoints were LV end-systolic volume (ESV), LV ejection fraction (EF), mitral regurgitation (MR), and a combination of heart failure (HF) events and cardiovascular hospitalizations. Overall, 108 patients were randomized (RV: 58; BIV: 50). Intention to treat and on-treatment analyses revealed no significant differences in any of the outcomes. Analysis of covariance (ANCOVA) difference for treatment according to randomization (in mL): LVEDV −3.92 (−18.71 to 10.85), P= 0.6; LVESV −1.38 (−12.07 to 9.31), P= 0.80; LVEF 2.47 (−3.00 to 7.94), P= 0.37. Analysis of covariance difference for the on-treatment analysis: LVEDV −4.90 (−20.02 to 10.22, PP= 0.52; LVESV −6.45 (−17.28 to 4.38), P= 0.24, LVEF 2.18 (−3.37 to 7.73), P= 0.44. Furthermore, secondary endpoints did not differ significantly. Conclusion This study did not demonstrate significant LV volume differences >12 months between RV apical and BIV pacing for AV block. Thus, BIV pacing cannot be recommended as a routine treatment for AV block in these patients. However, the results encourage and inform the design of subsequent larger trials with higher power for detecting small volume changes. ClinicalTrials.gov Identifier: NCT00170326.
ISSN: 1388-9842
URI: http://hdl.handle.net/2117/13107
DOI: 10.1093/eurjhf/hfr041
Apareix a les col·leccions:Altres. Enviament des de DRAC
GREMA - Grup de Recerca en Estadística Matemàtica i les seves Aplicacions. Articles de revista
Departament d'Estadística i Investigació Operativa. Articles de revista
Comparteix:


Stats Mostra les estadístiques d'aquest ítem

SFX Query

Aquest ítem (excepte textos i imatges no creats per l'autor) està subjecte a una llicència de Creative Commons Llicència Creative Commons
Creative Commons

 

Valid XHTML 1.0! Programari DSpace Copyright © 2002-2004 MIT and Hewlett-Packard Comentaris
Universitat Politècnica de Catalunya. Servei de Biblioteques, Publicacions i Arxius